Patents
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
04/2002
04/18/2002CA2425672A1 Use of substituted imidazo[1,2-a]-pyridin-,pyrimidin-and -pyrazin-3-yl-amine derivatives in the preparation of medicaments for inhibiting nos
04/18/2002CA2425666A1 Substituted 3.4-dihydro-pyrido[1,2-a]pyrimidines
04/18/2002CA2425650A1 Methods for the treatment of a traumatic central nervous system injury
04/18/2002CA2425649A1 Nitroderivatives as drugs for diseases having an inflammatory basis
04/18/2002CA2425581A1 Modulation of ligand binding/enzymatic activity of alpha beta proteins
04/18/2002CA2425520A1 N-alkylglycine trimeres capable of blocking the response to chemical substances, heat stimuli or mediators of neuronal receptor inflammation and compositions containing said trimeres
04/18/2002CA2425508A1 Targeted therapeutic agents
04/18/2002CA2425121A1 Ether compounds and compositions for cholesterol management and related uses
04/18/2002CA2424983A1 Nucleic acid molecules and polypeptides for immune modulation
04/18/2002CA2424951A1 Beta-amino acid derivatives as integrin receptor antagonists
04/18/2002CA2424292A1 Tricyclic compounds and uses thereof
04/18/2002CA2424107A1 Sulfonylguanidines
04/18/2002CA2424055A1 Medication delivery devices
04/18/2002CA2423935A1 Substituted c-cyclohexylmethylamine derivatives
04/18/2002CA2423515A1 Pyrazole derivatives for the treatment of viral diseases
04/18/2002CA2394084A1 Inhibitors of protein kinases
04/17/2002EP1197556A1 Useful polypeptide
04/17/2002EP1197553A1 Antisense nucleic acid against alphaV integrin
04/17/2002EP1197550A2 Methods and compositions for diagnosing and treating disorders involving angiogenesis
04/17/2002EP1197488A1 (2S)-2-(Adamantan-1-ylmethoxycarbonylamino)-3-(4-(2-(1,4,5,6-tetrahydropyrimidin-2-ylcarbamoyl)ethyl)benzoylamino)propionic acid isopropyl ester, its preparation and its use
04/17/2002EP1197484A2 1H-Indole-3-glyoxylamide sPLA2 inhibitors
04/17/2002EP1197225A1 REMEDIES FOR DISEASES CAUSED BY PTH OR PTHrP
04/17/2002EP1197209A1 Percutaneously absorbable preparations
04/17/2002EP1196579A2 Tryptase inhibitor
04/17/2002EP1196577A2 Cell cycle and proliferation proteins
04/17/2002EP1196574A2 Human proteins involved in detoxification
04/17/2002EP1196569A2 Electron transfer proteins
04/17/2002EP1196567A2 Human immune response molecules
04/17/2002EP1196450A1 Fibrin citrulline derivatives and their use for diagnosing or treating rheumatoid arthritis
04/17/2002EP1196441A1 Keratinocyte growth factor-2
04/17/2002EP1196440A2 Therapeutic peptides derived from subsequences of bpi
04/17/2002EP1196433A2 CYCLIC PEPTIDE DERIVATIVES AS INHIBITORS OF INTEGRIN ALPHA v BETA 6
04/17/2002EP1196432A2 FVIIa ANTAGONISTS
04/17/2002EP1196418A1 METHOD FOR PREPARING SUBSTITUTED 1,4]DIAZEPINO 6,7,1- i hi /i ]INDOL-4-ONES
04/17/2002EP1196416A1 Substituted purine derivatives as inhibitors of cell adhesion
04/17/2002EP1196411A1 Bradykinin b1 receptor antagonists
04/17/2002EP1196407A1 N-imidazolylmethyl carboxamides as nitric oxide production inhibitors
04/17/2002EP1196404A1 Piperazine derivatives as modulators of chemokine receptor activity
04/17/2002EP1196397A1 Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases
04/17/2002EP1196387A1 Azo amino acid derivatives for the treatment of neurological diseases
04/17/2002EP1196373A1 3-amino-2-benzyl-1-phenyl-propane derivatives
04/17/2002EP1196191A1 Death domain containing receptor 5
04/17/2002EP1196186A2 Promotion or inhibition of angiogenesis and cardiovascularization by tumor necrosis factor ligand/receptor homologs
04/17/2002EP1196180A1 Treatment of angiogenesis dependent conditions with dextrin sulphate
04/17/2002EP1196169A1 Compounds having cytokine inhibitory activity
04/17/2002EP1196162A1 Procyanidin oligomers for inhibiting matrix metalloproteinases and medicine having effective composition of same
04/17/2002EP1196161A1 Selective inhibition of cyclooxygenase-2
04/17/2002EP1196160A1 A synergistic combination: gabapentin and pregabalin
04/17/2002EP1196155A1 New use of compounds as antibacterial agents
04/17/2002EP1196147A1 Oral liquid compositions
04/17/2002EP1196136A1 Compositions comprising organosiloxane resins for delivering oral care substances
04/17/2002EP1196135A1 Compositions comprising organosiloxane resins for delivering oral care substances
04/17/2002EP1112079B1 Myrtle extract, preparation method and use
04/17/2002EP0937038B1 Vitamin d analogues
04/17/2002EP0934290B1 Aminothiazole derivatives, method of preparation and pharmaceutical compositions containing same
04/17/2002EP0901378B1 Pharmaceutical compositions containing cyclosporine and a carrier comprising at least an ester of alpha-glycerophosphoric acid
04/17/2002EP0880519B1 Thiazolylbenzofuran derivatives and pharmaceutical compositions containing them
04/17/2002EP0706395B1 Use of ropivacaine in the manufacture of a pharmaceutical with analgetic effect with minimal motor blockade
04/17/2002EP0660708B1 Phospholipids
04/17/2002EP0607178B1 Methods for the isolation and fusion of cells
04/17/2002EP0359783B2 Treatment of autoimmune diseases by oral administration of autoantigens
04/17/2002CN1345376A Protease, gene therefor and use thereof
04/17/2002CN1345336A Antibody and chemokine constructs and their use for treating autoimmune diseases
04/17/2002CN1345335A Melanocortin receptor ligands
04/17/2002CN1345332A C-terminal modified (N-substituted)-2 indolylcarbonyldiptides as inhibitors of ICE/CED-3 family of cysteine proteases
04/17/2002CN1345331A Method and composition for angiogenesis inhibition
04/17/2002CN1345329A Tumor mecrosis factor receptors 6 alpha and beta
04/17/2002CN1345317A (1-phenacy-3-phenyl-3-piperidylethyl)piperidine derivatives, method for production thereof and pharmaceutical compositions containing the same
04/17/2002CN1345314A Amine derivatives as protease inhibitors
04/17/2002CN1345312A Dibenzoazulene derivatives for treating thrombosis, osteoporosis arteriosclerosis
04/17/2002CN1345308A Acetylenic alpha-amino acid based sulfonamide hydroxamic acid TACE inhibitors
04/17/2002CN1345307A N-(2-phenyl-4-amino-butyl)-1-naphthamides as neurokinin-1 receptor antagonists
04/17/2002CN1345244A Herbal compositions and uses for treatment tof allergic reactions
04/17/2002CN1345189A Nutritional compositions with contain slightly negatively charged, non-digestible polysaccharides and use thereof for reducing transport through tight junctions
04/17/2002CN1344755A Prep. of degradable polymer, pharmaceutical composition containing the same and its use
04/17/2002CN1344560A Medicine mainly for treating arthralgia and apoplexy sequelae
04/17/2002CN1344557A Kidney invigorating and arthralgia eliminating granule
04/17/2002CN1344545A Chinese medicine prepn for treating rheumatoid arthritis and its prepn
04/17/2002CN1344540A Application of calcium L-threonate in treating cartilage related diseases
04/17/2002CN1082958C Alternate crystal form of tazofelone
04/17/2002CN1082950C Quinoline derivatives containing diol as leukotriene antagonists
04/17/2002CN1082820C Purified extract of harpagophytum procumbens and/or Harpagophytum zeyherii DENCE, process for its prodn. and its use
04/16/2002US6372926 17-side chain alkynyl-and 20-oxopregna-derivatives of vitamin D, methods for their production and pharmaceutical compositions thereof
04/16/2002US6372779 Anthracene derivatives with carbamoyl groups, amido groups, urea groups and sulfonamide groups
04/16/2002US6372777 Cyclic AMP-specific phosphodiesterase inhibitors
04/16/2002US6372773 Treatment of inflammation, arthritis with urea or thiourea heterocycles
04/16/2002US6372768 2-aminopyridines containing fused ring substituents
04/16/2002US6372758 Sulfamato hydroxamic acid metalloprotease inhibitor
04/16/2002US6372756 Narcotics or analgesics
04/16/2002US6372754 Drugs for treatment or prevention of depression, anxiety, pain, inflammation, migraine, emesis or postherpic neuralgia.
04/16/2002US6372743 Certain alkylene diamine-substituted pyrazlo (1,5-a)-1,5-pyrimidines and pyrazolo (1,5-a) 1,3,5-triazines
04/16/2002US6372731 Vitamin D derivatives with C-25 substituents, process for their preparation, intermediate products and their use in preparing medicaments
04/16/2002US6372719 ανβ3 integrin antagonists in combination with chemotherapeutic agents
04/16/2002US6372715 Use of erythropoientin and iron preparations for producing pharmaceutical combination preparations for treating rheumatic diseases
04/16/2002US6372473 Tissue plasminogen activator-like protease
04/16/2002US6372468 Useful in the development of human therapeutics and diagnostic formulations
04/16/2002US6372267 Cocoa solids prepared by heating, pressing, recovering partially defatted cocoa solids which contain cocoa polyphenols including cocoa procyanidins
04/16/2002US6372197 Methods and compositions using norastemizole in combination with leukotriene inhibitors
04/16/2002CA2260413C Terpenoid lactone compounds and their production process
04/16/2002CA2087414C Arylcycloalkyl derivatives their production and their use